← BWX overview

BWX vs Rolls-Royce: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

BWX Technologies Inc (BWXT)

Q3 2026
▲4

BWXT Q3: Guidance Raised, Backlog Surges, New Nuclear Deals

  • Guidance raised after strong Q2 results BWXT raised its full-year guidance after Q2 revenue rose 18% to $901.6 million and earnings per share beat estimates. This shows the company is performing better than expected and expects continued strength.

    Guidance raise and earnings beat are key new positive developments that directly affect investor expectations.

  • Backlog jumps 39.6% to $8.4 billion BWXT's backlog surged 39.6% to $8.4 billion, indicating strong future revenue visibility. This growth reflects robust demand across its nuclear defense and commercial businesses.

    Backlog growth is a critical indicator of future revenue and was not mentioned in earlier reports.

  • New contracts: Army microreactor and Canadian nuclear plant BWXT won a U.S. Army contract for the Janus microreactor and a deal for a Canadian transportable nuclear plant. These expand its footprint in mobile and small nuclear power.

    These are new contract wins that open additional revenue streams and demonstrate BWXT's technological leadership.

  • First investment-grade rating and strategic portfolio moves BWXT secured its first investment-grade credit rating (BBB) and sold its medical unit for $800 million, sharpening focus on core nuclear operations. The Saudi 30-year nuclear pact also boosts long-term prospects.

    These strategic actions improve financial flexibility and focus, supporting growth and shareholder value.

September 2026
▲4

BWXT Wins New Reactor Deals, Expands Capacity, Targets $6B Revenue by 2030

  • U.S. Army Janus Program Selection BWXT was chosen to deploy its BANR microreactor for the U.S. Army's Janus program, with the first unit planned at Fort Campbell. This is a major government contract that adds long-term revenue and validates BWXT's advanced reactor technology, pushing the stock up.

    This is a new, significant contract win that directly boosts future demand and revenue visibility.

  • Manufacturing Expansion and Strong 2025 Revenue BWXT expanded its Cambridge, Ontario facility and is investing in uranium processing and advanced manufacturing. Its 2025 revenue rose 18.3% to $3.2 billion, with projected EPS growth ahead. This shows execution and capacity to meet rising nuclear demand, supporting the stock.

    It highlights tangible growth and investment that underpin future earnings.

  • Inaugural Investment Grade Credit Rating Fitch gave BWXT its first investment grade rating of BBB with a stable outlook, citing its strong market position and cash flow. This lowers borrowing costs and signals financial health, which can attract more investors and lift the stock.

    A new credit rating improves BWXT's financial profile and investor appeal.

  • Investor Day Targets and Canadian Microreactor Deal BWXT set 2030 revenue targets of $5.5–$6 billion, doubled its backlog to $8.4 billion, and is selling a non-core unit to fund nuclear growth. It also won a Canadian transportable nuclear plant project. These moves clarify long-term growth and add new demand, supporting the stock despite a recent pullback.

    These are new strategic updates that directly address future growth and market opportunities.

Latest
▲4

BWXT Wins New Reactor Deals, Expands Capacity, Targets $6B Revenue by 2030

  • U.S. Army Janus Program Selection BWXT was chosen to deploy its BANR microreactor for the U.S. Army's Janus program, with the first unit planned at Fort Campbell. This is a major government contract that adds long-term revenue and validates BWXT's advanced reactor technology, pushing the stock up.

    This is a new, significant contract win that directly boosts future demand and revenue visibility.

  • Manufacturing Expansion and Strong 2025 Revenue BWXT expanded its Cambridge, Ontario facility and is investing in uranium processing and advanced manufacturing. Its 2025 revenue rose 18.3% to $3.2 billion, with projected EPS growth ahead. This shows execution and capacity to meet rising nuclear demand, supporting the stock.

    It highlights tangible growth and investment that underpin future earnings.

  • Inaugural Investment Grade Credit Rating Fitch gave BWXT its first investment grade rating of BBB with a stable outlook, citing its strong market position and cash flow. This lowers borrowing costs and signals financial health, which can attract more investors and lift the stock.

    A new credit rating improves BWXT's financial profile and investor appeal.

  • Investor Day Targets and Canadian Microreactor Deal BWXT set 2030 revenue targets of $5.5–$6 billion, doubled its backlog to $8.4 billion, and is selling a non-core unit to fund nuclear growth. It also won a Canadian transportable nuclear plant project. These moves clarify long-term growth and add new demand, supporting the stock despite a recent pullback.

    These are new strategic updates that directly address future growth and market opportunities.

August 2026
▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

  • Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.

    This is a new, major demand driver that expands BWXT's addressable market.

  • Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.

    This is the core financial update that directly lifts investor expectations and the stock price.

  • Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.

    This strategic move frees up capital and refocuses the company on higher-growth areas.

  • Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.

    A record backlog is a key indicator of future sales and earnings power.

▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

  • Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.

    This is a new, major demand driver that expands BWXT's addressable market.

  • Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.

    This is the core financial update that directly lifts investor expectations and the stock price.

  • Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.

    This strategic move frees up capital and refocuses the company on higher-growth areas.

  • Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.

    A record backlog is a key indicator of future sales and earnings power.

Q2 2026
▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

  • mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.

    New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.

  • Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.

    Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.

  • Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.

    New analyst actions reflect improving sentiment and can influence short-term demand for the stock.

  • Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.

    New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

June 2026
▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

  • mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.

    New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.

  • Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.

    Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.

  • Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.

    New analyst actions reflect improving sentiment and can influence short-term demand for the stock.

  • Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.

    New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

  • mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.

    New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.

  • Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.

    Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.

  • Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.

    New analyst actions reflect improving sentiment and can influence short-term demand for the stock.

  • Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.

    New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

Rolls-Royce Holdings PLC (RR.LSE)

Q3 2026
▲3▼1

Rolls-Royce profit jumps, guidance raised on defense and power demand

  • H1 profit surge and raised guidance Rolls-Royce's first-half operating profit jumped 46% to £2.5bn, prompting the company to raise its full-year profit guidance to £4.7–4.9bn. This strong financial performance was the main driver of the stock's rise.

    The profit beat and guidance raise are the central new financial events that directly lifted the shares.

  • Defense and power systems growth A £15bn boost to the UK defense budget supports Rolls-Royce's £17.4bn order backlog. Meanwhile, its power systems unit benefits from a looming 100GW US power shortfall and booming data-center demand, with orders up over half and another hyperscaler deal near.

    These are new, concrete demand drivers that underpin future revenue and were highlighted as key positives this period.

  • New nuclear deals Rolls-Royce signed new nuclear agreements in Sweden, the UK, and Japan, adding long-term revenue potential. These deals strengthen its position in the small modular reactor market and support future growth.

    The nuclear deals are a fresh positive development that expands the company's long-term opportunity pipeline.

  • SMR sourcing and weak China luxury demand Risks remain: SMR reactor vessels must be sourced overseas, angering UK politicians and unions and potentially delaying approvals. Chinese luxury car demand is still weak, and quantum computing work is only an early-stage positive signal.

    These are the main counterweights that could cap gains or delay projects, providing a balanced view.

July 2026
▲3▼1

Rolls-Royce profit jumps, guidance raised on defense and power demand

  • H1 profit surge and raised guidance Rolls-Royce's first-half operating profit jumped 46% to £2.5bn, prompting the company to raise its full-year profit guidance to £4.7–4.9bn. This strong financial performance was the main driver of the stock's rise.

    The profit beat and guidance raise are the central new financial events that directly lifted the shares.

  • Defense and power systems growth A £15bn boost to the UK defense budget supports Rolls-Royce's £17.4bn order backlog. Meanwhile, its power systems unit benefits from a looming 100GW US power shortfall and booming data-center demand, with orders up over half and another hyperscaler deal near.

    These are new, concrete demand drivers that underpin future revenue and were highlighted as key positives this period.

  • New nuclear deals Rolls-Royce signed new nuclear agreements in Sweden, the UK, and Japan, adding long-term revenue potential. These deals strengthen its position in the small modular reactor market and support future growth.

    The nuclear deals are a fresh positive development that expands the company's long-term opportunity pipeline.

  • SMR sourcing and weak China luxury demand Risks remain: SMR reactor vessels must be sourced overseas, angering UK politicians and unions and potentially delaying approvals. Chinese luxury car demand is still weak, and quantum computing work is only an early-stage positive signal.

    These are the main counterweights that could cap gains or delay projects, providing a balanced view.

Latest
▲2▼2

Rolls-Royce wins new nuclear deals but faces UK content scrutiny

  • Sweden SMR contract and UK/Japan nuclear tech deals Rolls-Royce won a contract to build three small modular reactors in Sweden and signed nuclear technology agreements with the UK and Japan. These deals turn policy support into real revenue commitments, strengthening the long-term growth story and supporting the share price.

    This is a new, concrete win that adds to Rolls-Royce's nuclear order book and future revenue.

  • Overseas sourcing for SMR reactor vessels raises political risk Rolls-Royce is buying key reactor parts from South Korea or the Czech Republic because no UK supplier can make them. This has upset UK politicians and unions, and could slow approvals or force costly changes, weighing on the SMR programme and the shares.

    It is a new negative development that could delay or complicate a key growth project.

  • Quantum computing partnership for turbine design Rolls-Royce is working with Quantinuum and others to explore quantum computing for designing better gas turbines. If successful, this could cut development costs and improve engine performance over time, a small but positive long-term signal for the shares.

    It is a new technology collaboration that could enhance future competitiveness.

  • China consumer weakness hits luxury car sales Rolls-Royce car sales in China have fallen as consumers there spend less on luxury goods. While the decline is less severe than for mass-market brands, it still points to weaker demand in a key market, a mild drag on sentiment for the company.

    It is a new data point showing demand pressure in an important region.

▲4

Rolls-Royce Soars on Record Profit Upgrade and Booming Defense & AI Demand

  • UK defense budget boost lifts demand outlook The UK unveiled a £15 billion defense spending increase, raising the budget to 2.7% of GDP by 2029. This directly benefits Rolls-Royce's defense arm, which already has a £17.4 billion order backlog, by increasing future orders for military engines and services.

    This is a major new demand driver for Rolls-Royce's defense business, directly boosting future revenue and profit potential.

  • US power shortfall opens new market for gas engines Bank of America warns of a 100-gigawatt US electricity shortfall by 2030, with data centers driving demand. Natural gas turbines are sold out, pushing developers to Rolls-Royce's gas reciprocating engines, creating a new growth avenue beyond aerospace.

    This highlights a new, large addressable market for Rolls-Royce's power systems segment, driven by AI data center growth.

  • H1 profit jumps 46%, guidance raised sharply Rolls-Royce reported a 46% rise in first-half operating profit to £2.5 billion and raised full-year guidance to £4.7-4.9 billion, up from £4-4.2 billion. Strong performance across civil aerospace, defense, and power systems drove the beat, with free cash flow also rising.

    This is the core earnings event that directly validates the company's turnaround and boosts investor confidence.

  • Data center orders surge, hyperscaler deal imminent Rolls-Royce's power systems unit grew organic revenue 28% and profit 72%, with the data center order book expanding by over half in H1. The CEO said another major hyperscaler deal is near, and orders are already being taken for 2028, signaling strong future growth.

    This shows concrete momentum in the fast-growing data center power business, a key new profit engine.